N-linked glycoprotein

N-linked glycoproteins are a broad class of proteins characterized by the covalent attachment of oligosaccharides (glycans) to the nitrogen atom of asparagine residues, a process essential for proper protein folding, stability, and intracellular trafficking (NCBI, 2022). These molecules are ubiquitous on cell surfaces and in secreted fluids, where they mediate critical biological processes such as cell-cell recognition, immune system modulation, and signal transduction (UniProt, 2023). In various pathological states, particularly cancer, aberrant N-glycosylation patterns contribute to tumor progression, metastasis, and the evasion of host immune surveillance (PubMed, 2021). While the entire class of N-linked glycoproteins is too broad to be considered a single therapeutic target, many individual members, such as PD-L1, HER2, and EGFR, are major targets for monoclonal antibodies and targeted therapies (StatPearls, 2023). Pharmacological agents like tunicamycin and iminosugars can inhibit the N-glycosylation pathway, but their clinical utility is often limited by significant safety concerns related to the disruption of essential cellular functions (Journal of Biological Chemistry, 2019).

Other names

N-glycosylated proteinAsparagine-linked glycoproteinAsn-linked glycoproteinN-glycan-containing protein

Inhibition of N-glycan biosynthesis or processing enzymes (e.g., oligosaccharyltransferase, glucosidases, or mannosidases) to disrupt protein maturation and function.